Prognostic factors and treatment outcomes in patients with operated endometrial cancer: analysis of 674 patients at a single institutionA Yoney
Okmeydani Training and Research Hospital, Department of Radiation Oncology, Istanbul, Turkey
J BUON 16:64-73. 2011
..Endometrial carcinoma is the most prevalent gynecologic tumor in developed countries. The aim of the present study was to evaluate the clinical characteristics of the patients with endometrial cancer...
Low risk stage I endometrial carcinoma: prognostic factors and outcomesA Yoney
Okmeydani Training and Research Hospital, Department of Radiation Oncology, Sisli, Istanbul, Turkey
Indian J Cancer 48:204-10. 2011
....
- Postoperative chemoradiation in patients with localized gastric adenocarcinoma: single center experience
A Yoney
Department of Radiation Oncology, Okmeydani Training and Research Hospital, Istanbul, Turkey
Indian J Cancer 48:24-30. 2011
....
- A retrospective study of treatment and outcome in 39 cases of male breast cancer
Adnan Yoney
Okmeydani Training and Research Hospital, Istanbul, Turkey
Hematol Oncol Stem Cell Ther 1:98-105. 2008
..We evaluated our own results in the treatment of male breast cancer patients with respect to local control (LC), overall survival (OS) and possible prognostic factors for survival...
- A retrospective comparison of concurrent bolus 5-fluorouracil or raltitrexed in preoperative chemoradiation for locally advanced rectal cancer
Adnan Yoney
Department of Radiation Oncology, Okmeydani Training and Research Hospital, Sisli, Istanbul, Turkey
Hematol Oncol Stem Cell Ther 1:28-33. 2008
..We retrospectively compared the toxicity, tumor downstaging, pathologic response and relapse rate with bolus FU or RA during concurrent radiotherapy (RT) to assess the role of RA in place of FU...
- A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma
A Yoney
Okmeydani Training and Research Hospital, Department of Radiation Oncology, Istanbul, Turkey
Cancer Radiother 14:19-23. 2010
..We retrospectively compared the toxicity, local and distant control and survival rates with FU or oral UFT during concurrent radiotherapy to assess the role of UFT instead of FU...
- Male breast cancer: a retrospective analysis
A Yoney
Department of Radiation Oncology, Okmeydani Training and Research Hospital, 34384 Sisli, Istanbul, Turkey
Cancer Radiother 13:103-7. 2009
..To evaluate our results in the treatment of male breast cancer patients with respect to local control (LC), overall survival (OS) and possible prognosis factors for survival...
- Retrospective analysis of 105 cases with uterine sarcoma
Adnan Yoney
Okmeydani Training and Research Hospital, Department of Radiation Oncology, 8 Cadde Inci 3 daire 8, Atasehir Kadikoy, 34578 Istanbul, Turkey
Bull Cancer 95:E10-7. 2008
..Our data favors treatment for uterine sarcoma with radical surgery plus radiotherapy alone over 54 Gy or with chemotherapy...
- Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers
Adnan Yoney
Department of Radiation Oncology, Okmeydani Training and Research Hospital, Sisli, Istanbul, Turkey
Onkologie 30:479-84. 2007
..Head and neck cancers are rapidly proliferating and relatively radiosensitive tumors. The increase in the number of daily fractions and the decrease in total treatment time give promising results in clinical practice...
- Patterns of care for lung cancer in radiation oncology departments of Turkey
Ayse Nur Demiral
Dokuz Eylul University Medical School, Department of Radiation Oncology, Izmir, Turkey
Int J Radiat Oncol Biol Phys 72:1530-7. 2008
..To determine the patterns of care for lung cancer in Turkish radiation oncology centers...
- An accelerated radiotherapy scheme using a concomitant boost technique for the treatment of unresectable stage III non-small cell lung cancer
Mustafa Izmirli
Yuzuncu Yil University, Faculty of Medicine, Department of Radiation Oncology, Arastirma Hastanesi Maras caddesi, Van, Turkey
Jpn J Clin Oncol 35:239-44. 2005
..We designed a phase II trial for evaluation of the efficacy and tolerability of an accelerated concomitant boost radiotherapy scheme for the treatment of the patients with non-small cell lung cancer (NSCLC)...
